Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-FU

Authors :: Cutsem, E. van
Cunningham, D.
Bokkel Huinink, W.W. ten
Punt, C.J.A.
Alexopoulos, C.
Dirix, L.Y.
Symann, M.
Blijham, G.H.
Cholet, P.
Fillet, G.
Groeningen, C.J. van
Vannetzel, J.M.
Levi, F.
Panagos, G.
Unger, C.
Wils, J.
Cote, C.
Blanc, C.
Herait, P.
Bleiberg, H.
Source :: European Journal of Cancer, 35, 54-59, European Journal of Cancer, 35, pp. 54-59
Publication Year :: 1999
Abstract: Item does not contain fulltext 6 p.

Tools